Suppl. Fig. 2. prps1a mutant phenotypes.
(A) The smaller eye phenotype in prps1a MZhom embryos at 1 dpf and 2 dpf. White arrow indicates easily visible reduction in size. (B) Reduced iridophores in prps1a MZhom at 5 dpf.
White arrows show where the reduction of iridophores in the head, trunk and yolk are most easily seen. (C) Retinal morphology of prps1a Zhom embryos at 3 dpf and 6 dpf. (D) Retinal morphology of prps1a MZhom embryos at 3 dpf and 6 dpf. CMZ, ciliary marginal zone. GCL, ganglion cell layer. IPL, inner plexiform layer. INL, inner nuclear layer. OPL, outer plexiform layer.
ONL, outer nuclear layer. PR, photoreceptor. RPE, retina pigment epithelium. Eyes are most reduced at 3 dpf, but begin to recover by day 6. (E) prps1a homozygous mutants have a normal number of neuromast hair cells at 5 dpf. The difference between the control and mutants is not significant (n=10, p=0.87).
Suppl. Fig. 3 . prps1a CRISPR mutant phenotypes. Phenotype classification was performed at 3 dpf, with 24 embryos displaying a morphology as shown in panel D, and 8 embryos as in panel E. Genotyping for prps1a mutation revealed 11/11 embryos as in panel D were wild-type or heterozygotes for prps1a, and 8/8 embryos as in panel E were homozygotes for prps1a.
Suppl. Table 1 . Somatic mutation analysis in prps1a CRISPR mutants.
Fluorescent PCR analysis was used to detect the prps1a mutations in the uninjected, Cas9 mRNA injected control, as well as Cas9 mRNA and prps1a gRNA co-injected prps1a CRISPR embryos. Size indicates the length (bp) of PCR amplicons. Height indicates the peak height of fluorescent signal. No wild-type amplicon was detected in either of the 10 prps1a CRISPR embryos.
